Koiso Takao, Satow Tetsu, Hamano Eika, Nishimura Masaki, Takahashi Jun C, Kataoka Hiroharu
Department of Neurosurgery, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
J Neuroendovasc Ther. 2022;16(3):141-146. doi: 10.5797/jnet.oa.2021-0034. Epub 2021 Aug 14.
To evaluate the efficacy and safety of interventional radiology (IVR) for aneurysmal subarachnoid hemorrhage (SAH) later than 3 days after onset.
A total of 71 patients between 2012 and 2017 who underwent endovascular coiling were divided into two groups according to the timing of treatment: Group E (treated within 3 days after onset) and group D (treated between 4 and 14 days after onset), and the outcomes between two groups were compared. A case-matched study was conducted to minimize the selection bias lying in this cohort.
There were 56 (78.9%) and 15 (21.1%) patients in groups E and D, respectively. In group D, all patients arrived at the hospital later than 3 days after onset. The rates of patients with WFNS grade 1, 2, 3 and the presence of vasospasm upon the access route to the targeted aneurysm at the time of IVR were significantly higher in group D than in group E (93.3% vs 60.7%; p = 0.027, 33.3% vs 3.6%; p = 0.0037, respectively). There were no significant differences in the rate of intraprocedural complications, symptomatic vasospasm, delayed cerebral infarction due to vasospasm, retreatment, or modified Rankin Scale (mRS) at discharge. After propensity score matching, there were no significant differences in the outcomes between two groups.
Prompt coiling for patients with ruptured aneurysms who arrived later than 3 days after onset can be safely performed, even if they had vasospasm upon the access route.
评估发病3天后行介入放射治疗(IVR)对动脉瘤性蛛网膜下腔出血(SAH)的疗效及安全性。
将2012年至2017年间接受血管内栓塞治疗的71例患者,根据治疗时机分为两组:E组(发病3天内治疗)和D组(发病4至14天治疗),比较两组的治疗结果。进行病例匹配研究以尽量减少该队列中的选择偏倚。
E组和D组分别有56例(78.9%)和15例(21.1%)患者。在D组中,所有患者发病后3天以上入院。IVR时,D组患者的WFNS 1级、2级、3级比例以及在进入目标动脉瘤的路径上出现血管痉挛的比例显著高于E组(分别为93.3%对60.7%;p = 0.027,33.3%对3.6%;p = 0.0037)。术中并发症发生率、症状性血管痉挛、血管痉挛导致的迟发性脑梗死、再次治疗或出院时改良Rankin量表(mRS)评分在两组间无显著差异。倾向评分匹配后,两组间的治疗结果无显著差异。
对于发病3天后就诊的破裂动脉瘤患者,即使在进入路径上存在血管痉挛,也可安全地进行及时栓塞治疗。